AMPH
Price
$26.85
Change
+$0.49 (+1.86%)
Updated
Sep 26 closing price
Capitalization
1.25B
43 days until earnings call
BHC
Price
$6.48
Change
+$0.02 (+0.31%)
Updated
Sep 26 closing price
Capitalization
2.4B
32 days until earnings call
Interact to see
Advertisement

AMPH vs BHC

Header iconAMPH vs BHC Comparison
Open Charts AMPH vs BHCBanner chart's image
Amphastar Pharmaceuticals
Price$26.85
Change+$0.49 (+1.86%)
Volume$291.26K
Capitalization1.25B
Bausch Health Companies
Price$6.48
Change+$0.02 (+0.31%)
Volume$847.92K
Capitalization2.4B
AMPH vs BHC Comparison Chart in %
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. BHC commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a StrongBuy and BHC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (AMPH: $26.85 vs. BHC: $6.48)
Brand notoriety: AMPH: Not notable vs. BHC: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMPH: 54% vs. BHC: 29%
Market capitalization -- AMPH: $1.25B vs. BHC: $2.4B
AMPH [@Pharmaceuticals: Generic] is valued at $1.25B. BHC’s [@Pharmaceuticals: Generic] market capitalization is $2.4B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileBHC’s FA Score has 0 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • BHC’s FA Score: 0 green, 5 red.
According to our system of comparison, BHC is a better buy in the long-term than AMPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 5 TA indicator(s) are bullish while BHC’s TA Score has 4 bullish TA indicator(s).

  • AMPH’s TA Score: 5 bullish, 4 bearish.
  • BHC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AMPH is a better buy in the short-term than BHC.

Price Growth

AMPH (@Pharmaceuticals: Generic) experienced а -2.86% price change this week, while BHC (@Pharmaceuticals: Generic) price change was -3.71% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

AMPH is expected to report earnings on Nov 10, 2025.

BHC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHC($2.4B) has a higher market cap than AMPH($1.25B). BHC has higher P/E ratio than AMPH: BHC (24.92) vs AMPH (10.06). BHC YTD gains are higher at: -19.603 vs. AMPH (-27.687). BHC has higher annual earnings (EBITDA): 3B vs. AMPH (248M). BHC has more cash in the bank: 1.73B vs. AMPH (232M). AMPH has less debt than BHC: AMPH (655M) vs BHC (21.7B). BHC has higher revenues than AMPH: BHC (9.86B) vs AMPH (723M).
AMPHBHCAMPH / BHC
Capitalization1.25B2.4B52%
EBITDA248M3B8%
Gain YTD-27.687-19.603141%
P/E Ratio10.0624.9240%
Revenue723M9.86B7%
Total Cash232M1.73B13%
Total Debt655M21.7B3%
FUNDAMENTALS RATINGS
AMPH vs BHC: Fundamental Ratings
AMPH
BHC
OUTLOOK RATING
1..100
7484
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
35
Fair valued
PROFIT vs RISK RATING
1..100
87100
SMR RATING
1..100
48100
PRICE GROWTH RATING
1..100
6363
P/E GROWTH RATING
1..100
8536
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (35) in the Pharmaceuticals Other industry is in the same range as AMPH (67). This means that BHC’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's Profit vs Risk Rating (87) in the Pharmaceuticals Other industry is in the same range as BHC (100). This means that AMPH’s stock grew similarly to BHC’s over the last 12 months.

AMPH's SMR Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for BHC (100). This means that AMPH’s stock grew somewhat faster than BHC’s over the last 12 months.

AMPH's Price Growth Rating (63) in the Pharmaceuticals Other industry is in the same range as BHC (63). This means that AMPH’s stock grew similarly to BHC’s over the last 12 months.

BHC's P/E Growth Rating (36) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMPH (85). This means that BHC’s stock grew somewhat faster than AMPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHBHC
RSI
ODDS (%)
Bearish Trend 3 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 7 days ago
73%
Bullish Trend 11 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
72%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UBVTX81.850.90
+1.11%
Undiscovered Managers Behavioral Val R3
IVFIX4.370.03
+0.69%
Federated Hermes Intl Strat Val Div IS
VMVFX17.050.11
+0.65%
Vanguard Global Minimum Volatility Inv
CFVLX34.640.21
+0.61%
Commerce Value
RGSCX23.020.11
+0.48%
Virtus KAR Global Small-Cap C

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
+1.86%
AMRX - AMPH
34%
Loosely correlated
+1.56%
ZTS - AMPH
33%
Loosely correlated
+1.68%
VTRS - AMPH
29%
Poorly correlated
+0.32%
HROW - AMPH
29%
Poorly correlated
+2.06%
DRRX - AMPH
28%
Poorly correlated
N/A
More

BHC and

Correlation & Price change

A.I.dvisor tells us that BHC and AMRX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and AMRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
+0.31%
AMRX - BHC
33%
Poorly correlated
+1.56%
AMPH - BHC
27%
Poorly correlated
+1.86%
PAHC - BHC
26%
Poorly correlated
+2.02%
DRRX - BHC
26%
Poorly correlated
N/A
SWDCF - BHC
25%
Poorly correlated
N/A
More